Navigation Links
Regeneron's Eylea Now Captures One-Quarter Of Wet AMD Patient Share, Surpassing Share Of Roche/Genentech's Lucentis
Date:8/15/2013

EXTON, Penn., Aug. 15, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that surveyed retinal specialists/general ophthalmologists now treat 26 percent of their intravitreal pharmaceutically treated wet age-related macular degeneration (AMD) patients with Regeneron's Eylea, a significant increase from one year ago. Eylea has been on the market since November 2011. In fact, patient share for Eylea now surpasses that for Roche/Genentech's Lucentis (21 percent), which has been available since 2006. However, off-label use of Roche/Genentech's Avastin continues to dominate the wet AMD market, largely due to its low cost relative to the other anti-vascular endothelial growth factor (VEGF) agents and proven efficacy.

According to the TreatmentTrends®: Dry/Wet AMD (US) report, physician preference for Eylea is likely driven by its convenient twice monthly dosing frequency, which is supported by the finding that wet AMD patients receive significantly fewer Eylea injections than Avastin or Lucentis injections during the first two years of treatment. Data from the report also suggest that Eylea is moving up in the wet AMD treatment algorithm and is now the most preferred branded therapy indicated for the treatment of wet AMD, with Lucentis being the typical third-line treatment option.

"This shift in Eylea use is likely motivated by prescribers' high satisfaction with the agent and their positive perceptions related to its efficacy," said BioTrends Research Group Senior Business Insights Analyst Emma Williams, Ph.D. "These perceptions will contribute to the continued growth of Eylea patient share over the next six months and will trail only Avastin's patient share."

Report findings also reveal that surve
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Watching, Reading and Listening: A New Way to Interact with Patient Information
5. Phreesia identifies over 26% of patients who require additional autism evaluation
6. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
10. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
11. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) ... second quarter and year-to-date 2014 financial results on Monday, ... financial markets. The earnings press release will be accessible ... www.anipharmaceuticals.com . Arthur S. Przybyl ... C. Arnold , Vice President and Chief Financial Officer, ...
(Date:7/28/2014)... CLARA, Calif. , July 28, 2014  ProteinSimple ... assay for the Simple Western. This new assay allows users ... For the first time, Simple Western users can analyze ... The Simple Western has changed protein analysis as ... hassles of Western blot protocols - no messy gels, ...
(Date:7/28/2014)... 2014 OmPrompt today announces ... help it meet the global demand for customer ... logistics. Albion joins Shackleton Ventures.      ... the past 18 months OmPrompt has underpinned accelerated ... team and its operations. The new funding will ...
Breaking Medicine Technology:ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2ProteinSimple Says "Never Run a Gel Again!" 2OmPrompt Funded for Customer Automation Management Market Expansion 2
... 30 Transgenomic, Inc. (OTC,Bulletin Board: TBIO), a ... National Cancer Institute had approved a proposal to,perform ... in,the NCI 60 cancer cell line panel., ... warning,signal in several different types of cancer. This ...
... Spherix Incorporated,(Nasdaq: SPEX ) announced today that it ... manufacturer of bulk pharmaceutical ingredients,to supply a portion of ... of the unique sugar as a treatment for Type ... Practice) production batches,of D- tagatose for the Spherix New ...
Cached Medicine Technology:Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 2Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 3Spherix D-tagatose to be Supplied by Inalco SpA 2
(Date:7/28/2014)... According to court documents, the conflict dates to November ... Group (TMG), met with Rafael H. Harel, principal owner ... a broad project outline, were agreed upon for the development ... and marketing. , Though Caller continued to express ... of the project, praise was not accompanied by payment. The ...
(Date:7/28/2014)... 2014 TherapySites, the leading ... announced today its affiliation with the Illinois Association ... relationship allows TherapySites to continue to extend their online ... promotional offers. , “There has been a fundamental shift ... With nearly 3 billion Internet users, it is so ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According to the ... is a comprehensive guide that will help people get rid ... readers all the necessary information about heartburn and acid reflux. ... truth about heartburn , and risk factors for reflux disease. ... will help people get rid of symptoms of reflux disease ...
(Date:7/28/2014)... New York, NY (PRWEB) July 28, 2014 ... completed the exit of its investment in Loftware, Inc., ... Partners of Boston. Shore Points was the lead investor ... which the Company has become the leading international provider ... applications. , “Loftware has been a great investment for ...
(Date:7/27/2014)... 28, 2014 Hyaluronic Acid can hold ... the key to the power of Hyaluronic Serums. , ... Heshelow, founder of Sublime Beauty®. "But like collagen, it ... as ours improves skin moisture-retention and radiance." , ... to a healthy and beautiful look. Key Ingredients in ...
Breaking Medicine News(10 mins):Health News:Calko Medical Center Loses Website Twice over Non-Payment, According to Court Documents 2Health News:TherapySites (Websites for Therapists) Partners with the Illinois Association for Marriage and Family Therapy 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3Health News:Shore Points Capital Announces Sale of Portfolio Company Loftware 2Health News:Aging or Dry Skin Benefits from Hyaluronic Serum; Now 30% Off Sale at Sublime Beauty® 2
... Parental Loss Support Group helps adults cope with feelings of grief after ... 2nd, 10:00-11:30am, at Hospice By The Bay, 17 East Sir Francis Drake ... ... Hospice By The Bay,s eight-week Parental Loss Support Group helps adults ...
... Inc., a leading online retailer of contact lenses in the United States ... dry winter eyes can be easily prevented. , ... Bellevue, WA (PRWEB) ... retailer of contact lenses in the United States wants to ...
... marijuana use may significantly increase a man,s risk of ... to a study by researchers at Fred Hutchinson Cancer ... 9 in the journal Cancer ., The researchers ... of diagnosis was associated with a 70 percent increased ...
... less likely to survive the disease than white women, and ... decades to narrow this racial difference. That is the conclusion ... issue of CANCER , a peer-reviewed journal of the ... black women are more likely to die from uterine cancers ...
... 2009 Introduced by Congressman LewisWASHINGTON, Feb. 8 ... to help blind persons receiving Social Security Disability ... Blind Persons Return to Work Act of 2009 ... persons from reentering the workforce and will facilitate ...
... in the blood that influences immune cell migration also ... the build-up and breakdown of bones in the body. ... may provide a new target for scientists developing therapies ... rheumatoid arthritis. , The study comes from ...
Cached Medicine News:Health News:Hospice By The Bay Grief Group Helps Adults Who've Lost a Parent 2Health News:Contact Lens Wearers Should Blink More Often During Winter - Tips from VisionDirect.com to Keep Eyes Moist During Dry Winter Months 2Health News:Contact Lens Wearers Should Blink More Often During Winter - Tips from VisionDirect.com to Keep Eyes Moist During Dry Winter Months 3Health News:Marijuana use linked to increased risk of testicular cancer 2Health News:Marijuana use linked to increased risk of testicular cancer 3Health News:Marijuana use linked to increased risk of testicular cancer 4Health News:Black women with uterine cancers more likely to die than white patients 2Health News:National Federation of the Blind Praises Bill to Create Work Incentives and Opportunity 2Health News:Scientists discover key factor in controlling the breakdown of bone 2Health News:Scientists discover key factor in controlling the breakdown of bone 3
Silicone Flat Hubless Drains...
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe....
... manipulation and removal in the ... wire allows the basket to ... torsion. The unique tipless design ... damage and perforation. Supplied sterile ...
Used for internal biliary drainage. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: